ArticleBritish journal of cancer2013

HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.

D Groheux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.